Recall Record

Malvern, PA, United States

Endo Pharmaceuticals, Inc. recalls

3 recalls recorded since 2018, most recently on 10 July 2024. None are listed as ongoing. Status and classification are as published by the FDA.

Recalls3
Ongoing (FDA)0
Terminated or completed3
Class I (FDA)2

Terminated Class I Drugs

Recall started
10 July 2024
Terminated
16 September 2025
Reason
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg. The blister strips inside the product carton reflect the correct strength of 0.25 mg.
Distribution
Nationwide in the USA and Puerto Rico
Initiated
Voluntary: Firm initiated
Recall number
D-0622-2024

Terminated Class II Drugs

Recall started
2 March 2023
Terminated
8 November 2024
Reason
Failed Impurities/Degradation Specifications and Subpotent Drug: High Out of Specification results for a known and unknown impurity as well as low Out of Specification results for assay.
Distribution
Nationwide in the USA and Puerto Rico
Initiated
Voluntary: Firm initiated
Recall number
D-0475-2023

Terminated Class I Drugs

Recall started
17 September 2018
Terminated
4 February 2020
Reason
Labeling: Incorrect Instructions: Dosage information on the immediate container label incorrectly states "Two to four tablets four times daily." rather than the correct dosage of "Two tablets three times daily."
Distribution
Nationwide in the USA.
Initiated
Voluntary: Firm initiated
Recall number
D-0009-2019

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.